<qa>  What is the current pharmacotherapy regimen for patients with treatment-resistant depression?Patients with treatment-resistant depression TRD were assigned to two treatment groups in addition to their current pharmacotherapy regimen : one group received 5 active-rTMS before Electroconvulsive therapy ECT and the other one received sham-rTMS before ECT. The depressive symptoms and the cognitive functions are evaluated before rTMS, after 5 rTMS and after 5 ECT. 